Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Dihydrocodeine tartrate 10 mg and paracetamol 500 mg oral tablet |
Has active ingredient |
False |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
|
Dihydrocodeine tartrate 20 mg and paracetamol 500 mg oral tablet |
Has active ingredient |
False |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
|
Dihydrocodeine tartrate 30 mg and paracetamol 500 mg oral tablet |
Has active ingredient |
False |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
|
paracetamol + dihydrokodein |
Has active ingredient |
False |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
|
acetylsalicylsyra + koffein + dihydrokodeinbitartrat |
Has active ingredient |
False |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
|
Caffeine 30 mg and dihydrocodeine tartrate 16 mg and paracetamol 356.4 mg oral capsule |
Has active ingredient |
False |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
|
paracetamol + koffein + dihydrokodeinbitartrat |
Has active ingredient |
False |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
|
Product containing precisely caffeine 60 milligram and dihydrocodeine tartrate 32 milligram and paracetamol 712.8 milligram/1 each conventional release oral tablet (clinical drug) |
Has active ingredient |
False |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
|
Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug) |
Has active ingredient |
False |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
|
dihydrokodeintartrat 60 mg, tablett med modifierad frisättning |
Has active ingredient |
False |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
|
dihydrokodeintartrat 120 mg, tablett med modifierad frisättning |
Has active ingredient |
False |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
|
dihydrokodeintartrat 90 mg, tablett med modifierad frisättning |
Has active ingredient |
False |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
|
dihydrokodeintartrat 50 mg/ml, injektionsvätska, lösning, ampull 1 ml |
Has active ingredient |
False |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
|
Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
False |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
1 |
Dihydrocodeine tartrate 10 mg and paracetamol 500 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
2 |
Dihydrocodeine tartrate 20 mg and paracetamol 500 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
2 |
Caffeine 30 mg and dihydrocodeine tartrate 16 mg and paracetamol 356.4 mg oral capsule |
Has basis of strength substance (attribute) |
False |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
1 |
Dihydrocodeine tartrate 10 mg and paracetamol 500 mg oral tablet |
Has active ingredient |
False |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
1 |
Dihydrocodeine tartrate 10 mg and paracetamol 500 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
1 |
Product containing precisely caffeine 60 milligram and dihydrocodeine tartrate 32 milligram and paracetamol 712.8 milligram/1 each conventional release oral tablet (clinical drug) |
Has active ingredient |
False |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
1 |
Product containing precisely caffeine 60 milligram and dihydrocodeine tartrate 32 milligram and paracetamol 712.8 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
1 |
Dihydrocodeine tartrate 30 mg and paracetamol 500 mg oral tablet |
Has active ingredient |
False |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
1 |
Dihydrocodeine tartrate 30 mg and paracetamol 500 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
1 |
Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug) |
Has active ingredient |
False |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
3 |
Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
False |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
3 |
Dihydrocodeine tartrate 20 mg and paracetamol 500 mg oral tablet |
Has active ingredient |
False |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
1 |
Dihydrocodeine tartrate 20 mg and paracetamol 500 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
1 |
Product containing precisely caffeine 60 milligram and dihydrocodeine tartrate 32 milligram and paracetamol 712.8 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
3 |
Caffeine 30 mg and dihydrocodeine tartrate 16 mg and paracetamol 356.4 mg oral capsule |
Has active ingredient |
False |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
3 |
Caffeine 30 mg and dihydrocodeine tartrate 16 mg and paracetamol 356.4 mg oral capsule |
Has basis of strength substance (attribute) |
False |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
3 |
Product containing precisely dihydrocodeine tartrate 90 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
1 |
Product containing precisely dihydrocodeine tartrate 90 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
1 |
Product containing precisely dihydrocodeine tartrate 60 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
1 |
Product containing precisely dihydrocodeine tartrate 60 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
1 |
Product containing precisely dihydrocodeine tartrate 120 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
1 |
Product containing precisely dihydrocodeine tartrate 120 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
1 |
Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
False |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
1 |
Dihydrocodeine tartrate 20 mg and paracetamol 500 mg oral tablet |
Has precise active ingredient |
False |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
2 |
Dihydrocodeine tartrate 30 mg and paracetamol 500 mg oral tablet |
Has precise active ingredient |
True |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
1 |
Caffeine 30 mg and dihydrocodeine tartrate 16 mg and paracetamol 356.4 mg oral capsule |
Has precise active ingredient |
False |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
1 |
Product containing precisely caffeine 60 milligram and dihydrocodeine tartrate 32 milligram and paracetamol 712.8 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
3 |
Dihydrocodeine tartrate 10 mg and paracetamol 500 mg oral tablet |
Has precise active ingredient |
False |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
2 |
Dihydrocodeine tartrate 2 mg/mL oral solution |
Has precise active ingredient |
True |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
1 |
Dihydrocodeine tartrate 2 mg/mL oral solution |
Has basis of strength substance (attribute) |
True |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
1 |
dihydrokodeintartrat 50 mg/ml, injektionsvätska, lösning, ampull |
Has precise active ingredient |
False |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
1 |
dihydrokodeintartrat 50 mg/ml, injektionsvätska, lösning, ampull |
Has basis of strength substance (attribute) |
False |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
1 |
Product containing precisely dihydrocodeine tartrate 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
1 |
Product containing precisely dihydrocodeine tartrate 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
1 |
Product containing precisely dihydrocodeine tartrate 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
1 |
Product containing precisely dihydrocodeine tartrate 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
1 |
Dihydrocodeine tartrate 30 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
1 |
Dihydrocodeine tartrate 30 mg oral tablet |
Has precise active ingredient |
True |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
1 |
Product containing precisely dihydrocodeine tartrate 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
1 |
Product containing precisely dihydrocodeine tartrate 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
1 |
Dihydrocodeine tartrate 2.42 mg/mL oral solution |
Has precise active ingredient |
True |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
1 |
Dihydrocodeine tartrate 2.42 mg/mL oral solution |
Has basis of strength substance (attribute) |
True |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
1 |
Dihydrocodeine tartrate 10 mg and paracetamol 500 mg oral tablet |
Has precise active ingredient |
True |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
1 |
Dihydrocodeine tartrate 20 mg and paracetamol 500 mg oral tablet |
Has precise active ingredient |
True |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
1 |
Caffeine 30 mg and dihydrocodeine tartrate 16 mg and paracetamol 356.4 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
2 |
Caffeine 30 mg and dihydrocodeine tartrate 16 mg and paracetamol 356.4 mg oral capsule |
Has precise active ingredient |
True |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
2 |
Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
2 |
Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
2 |
Product containing precisely caffeine 60 milligram and dihydrocodeine tartrate 32 milligram and paracetamol 712.8 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
2 |
Product containing precisely caffeine 60 milligram and dihydrocodeine tartrate 32 milligram and paracetamol 712.8 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Dihydrocodeine tartrate |
Inferred relationship |
Some |
2 |